- Home
- CMPX vs TKNO Comparison
CMPX vs TKNO Comparison
Compare CMPX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- TKNO
- Stock Information
- Founded
- CMPX 2014
- TKNO 1996
- Country
- CMPX United States
- TKNO United States
- Employees
- CMPX N/A
- TKNO N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- CMPX Health Care
- TKNO Health Care
- Exchange
- CMPX Nasdaq
- TKNO Nasdaq
- Market Cap
- CMPX 291.8M
- TKNO 256.9M
- IPO Year
- CMPX N/A
- TKNO 2021
- Fundamental
- Price
- CMPX $2.97
- TKNO $4.69
- Analyst Decision
- CMPX Strong Buy
- TKNO
- Analyst Count
- CMPX 8
- TKNO 0
- Target Price
- CMPX $13.50
- TKNO N/A
- AVG Volume (30 Days)
- CMPX 1.3M
- TKNO 325.8K
- Earning Date
- CMPX 08-11-2025
- TKNO 08-07-2025
- Dividend Yield
- CMPX N/A
- TKNO N/A
- EPS Growth
- CMPX N/A
- TKNO N/A
- EPS
- CMPX N/A
- TKNO N/A
- Revenue
- CMPX N/A
- TKNO $38,923,000.00
- Revenue This Year
- CMPX N/A
- TKNO $8.73
- Revenue Next Year
- CMPX N/A
- TKNO $16.53
- P/E Ratio
- CMPX N/A
- TKNO N/A
- Revenue Growth
- CMPX N/A
- TKNO 11.40
- 52 Week Low
- CMPX $1.15
- TKNO $3.75
- 52 Week High
- CMPX $4.08
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- CMPX 50.84
- TKNO 49.37
- Support Level
- CMPX $2.66
- TKNO $4.39
- Resistance Level
- CMPX $3.47
- TKNO $4.97
- Average True Range (ATR)
- CMPX 0.25
- TKNO 0.42
- MACD
- CMPX -0.02
- TKNO 0.06
- Stochastic Oscillator
- CMPX 38.27
- TKNO 45.52
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.